Literature DB >> 12421595

Roles of cathepsins in reperfusion-induced apoptosis in cultured astrocytes.

Kazuhiro Takuma1, Makiko Kiriu, Koichi Mori, Eibai Lee, Riyo Enomoto, Akemichi Baba, Toshio Matsuda.   

Abstract

Astrocytic apoptosis may play a role in the central nervous system injury. We previously showed that reperfusion of cultured astrocytes with normal medium after exposure to hydrogen peroxide (H(2)O(2))-containing medium causes apoptosis. This study examines the involvement of the lysosomal enzymes cathepsins B and D in the astrocytic apoptosis. Reperfusion after exposure to H(2)O(2) caused a marked increase in caspase-3 and cathepsin D activities and a marked decrease in cathepsin B activity. Pepstatin A, an inhibitor of cathepsin D, and acetyl-L-aspartyl-L-methionyl-L-glutaminyl-L-aspart-1-aldehyde (Ac-DMQD-CHO), a specific inhibitor of caspase-3, blocked the H(2)O(2)-induced decrease in cell viability and DNA ladder formation in cultured rat astrocytes. The (L-3-trans-(propylcarbamoyl)oxirane-2-carbonyl)-L-isoleucyl-L-proline methyl ester (CA074 Me), a specific inhibitor of cathepsin B, did not affect the H(2)O(2)-induced cell injury. On the other hand, CA074 Me decreased cell viability with DNA ladder formation when cultured in the presence of Ac-DMQD-CHO. This caspase-independent apoptosis was attenuated by the addition of the cathepsin D inhibitor pepstatin A. Caspase-3 like activity was markedly inhibited by Ac-DMQD-CHO and partially by pepstatin A. Pepstatin A and CA074 Me inhibited cathepsin B and cathepsin D activities, respectively, in the presence and absence of Ac-DMQD-CHO. These results suggest that cathepsins B and D are involved in astrocytic apoptosis: cathepsin D acts as a death-inducing factor upstream of caspase-3 and the caspase-independent apoptosis is regulated antagonistically by cathepsins B and D.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12421595     DOI: 10.1016/s0197-0186(02)00077-3

Source DB:  PubMed          Journal:  Neurochem Int        ISSN: 0197-0186            Impact factor:   3.921


  8 in total

1.  Overexpression of both catalytically active and -inactive cathepsin D by cancer cells enhances apoptosis-dependent chemo-sensitivity.

Authors:  M Beaujouin; S Baghdiguian; M Glondu-Lassis; G Berchem; E Liaudet-Coopman
Journal:  Oncogene       Date:  2006-03-23       Impact factor: 9.867

2.  Edaravone protects PC12 cells from ischemic-like injury via attenuating the damage to mitochondria.

Authors:  Ying Song; Meng Li; Ji-cheng Li; Er-qing Wei
Journal:  J Zhejiang Univ Sci B       Date:  2006-09       Impact factor: 3.066

3.  Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation.

Authors:  Nadia H Moore; Lucio G Costa; Scott A Shaffer; David R Goodlett; Marina Guizzetti
Journal:  J Neurochem       Date:  2008-12-10       Impact factor: 5.372

4.  Cathepsin D overexpressed by cancer cells can enhance apoptosis-dependent chemo-sensitivity independently of its catalytic activity.

Authors:  Melanie Beaujouin; Emmanuelle Liaudet-Coopman
Journal:  Adv Exp Med Biol       Date:  2008       Impact factor: 2.622

5.  Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant.

Authors:  Daniel Offen; Yael Barhum; Eldad Melamed; Norbert Embacher; Christoph Schindler; Gerhard Ransmayr
Journal:  J Mol Neurosci       Date:  2008-07-24       Impact factor: 3.444

Review 6.  Cathepsin D expression levels in nongynecological solid tumors: clinical and therapeutic implications.

Authors:  Gaetano Leto; Francesca M Tumminello; Marilena Crescimanno; Carla Flandina; Nicola Gebbia
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  A novel bis-aryl urea compound inhibits tumor proliferation via cathepsin D-associated apoptosis.

Authors:  Jianping Wu; Yao Huang; Qian Xie; Junfeng Zhang; Zhen Zhan
Journal:  Anticancer Drugs       Date:  2020-06       Impact factor: 2.248

8.  Camalexin-induced apoptosis in prostate cancer cells involves alterations of expression and activity of lysosomal protease cathepsin D.

Authors:  Basil Smith; Diandra Randle; Roman Mezencev; LeeShawn Thomas; Cimona Hinton; Valerie Odero-Marah
Journal:  Molecules       Date:  2014-04-02       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.